SuperKine™ West Pico PLUS Chemiluminescent Substrate
Cat# BMU101-EN-500
Size : 500mL
Brand : Abbkine
Specification
Product name | SuperKine™ West Pico PLUS Chemiluminescent Substrate |
Applications notes | SuperKine™ West Pico PLUS Chemiluminescent Substrate provides a highly sensitive color developing solution to enhance the chemical signal of immunological experiments. In order to obtain the best experimental results, you need to optimize all your experimental factors, including the number of samples, antibody concentration, the use of membranes and blocking agents. |
Product Properties
Kit components | • ECL HRP Substrate Reagent A • ECL HRP Substrate Reagent B |
Features & Benefits | The SuperKine™ West Pico PLUS Chemiluminescent Substrate developed by Abbkine is based on the innovation and optimization of the classic peroxidase substrate system. It is used for enhanced chemiluminescence (ECL) and can directly replace other expensive ECL products without the need to renew Optimize experimental conditions. |
Usage notes | • Mix the two substrate components at a 1:1 ratio to prepare the substrate working solution. • Suggest 0.1-0.2ml of SuperLumia ECL working solution for 1 cm2 size of blot membrane. • Incubate blot 1-5 minutes in SuperLumia ECL Substrate working solution. • Drain excess reagent. Cover blot with clear plastic wrap. • Expose blot to X-ray film. |
Storage instructions | Stable for one year at 4-8°C from date of shipment. Exposure to the sun or any other intense light can harm the working solution. Short-term exposure to typical laboratory lighting will not harm the working solution. |
Shipping | Gel pack with blue ice. |
Precautions | The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product. |
Additional Information
Background | The family of ECL substrates is a series of premixed, ready-to-use chemiluminescent reagents for the detection of HRP-based Westerns. The SuperKine™ West Pico PLUS Chemiluminescent Substrate is specially optimized for picogram amounts of antigen detection on immunoblots, with pouring directly onto the blot membrane without worrying about pipetting error. The substrate's intense signal output and duration enables detection of picogram amounts of antigen with photographic or other imaging methods perfectly well. |
Image & description
-
Description of two different sizes.
The 100 mL size of the product is composed of Reagent A 50 mL and Reagent B 50 mL, and the 500 mL size is composed of Reagent A 250 mL and Reagent B 250 mL.
-
How long should the ECL working solution be incubated?
Under normal conditions, the ECL working solution can be incubated in 5-10 seconds, from incubation to exposure time of less than 30 seconds.
-
What is the detection range of this ECL?
Our company verified that the color solution has the best effect in the protein content range of 6.25-50 ng.
-
Crosstalk between 5-methylcytosine and N6-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic …(BMU101-EN-37.3)
Author:Tian, Yu, et al. Publication name:Molecular Cancer IF:37.3
-
Perturbated glucose metabolism augments epithelial cell proinflammatory function in chronic rhinosinusitis(BMU101-EN-14.29)
Author:Chen C L, Ma J, Lu R Y, et al. Publication name:Journal of Allergy and Clinical Immunology IF:14.29
-
Perturbated glucose metabolism augments epithelial cell proinflammatory function in chronic rhinosinusitis(BMU101-EN-14.2)
Author:Chen, Cai-Ling, et al. Publication name:Journal of Allergy and Clinical Immunology IF:14.2
-
PRMT5 methylating SMAD4 activates TGF-β signaling and promotes colorectal cancer metastasis(BMU101-EN-8)
Author:Liu, Anyi, et al. Publication name:Oncogene IF:8
-
Pyruvate dehydrogenase kinase 1–dependent metabolic reprogramming: A promising target for postmenopausal osteoporosis treatment(BMU101-EN-7.5)
Author:Xie, Dingbang, et al. Publication name:Biomedicine & Pharmacotherapy IF:7.5
-
The Role of the Dopamine System in Post-Stroke Mood Disorders in Newborn Rats(BMU101-EN-6.208)
Author:M Villa, M Martínez-Vega, A Del Pozo Publication name:International Journal of Molecular Sciences IF:6.208
-
Based on Nrf2/NLRP3 inflammasome signaling pathway to explore the prevention and treatment mechanism of gouty arthritis with Modified Simiaowan(BMU101-EN-5.4)
Author:Qin, Donger, et al. Publication name:Journal of Ethnopharmacology IF:5.4
-
Pharmacological inhibition of the cGAS-STING signaling pathway suppresses microglial M1-polarization in the spinal cord and attenuates neuropathic pain(BMU101-EN-5.273)
Author:Wu W, Zhang X, Wang S, et al. Publication name:Neuropharmacology IF:5.273
-
Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID(BMU101-EN-4.6)
Author:A Liu, Q Liu, S Leng, X Zhang, Q Feng Publication name:Clinical and Experimental Immunology IF:4.6
-
Knockdown of the long non‑coding RNA MALAT1 ameliorates TNF‑α‑mediated endothelial cell pyroptosis via the miR‑30c‑5p/Cx43 axis(BMU101-EN-3.4)
Author:ZJ Yang, R Liu, XJ Han, CL Qiu Publication name:Molecular Medicine Reports IF:3.4
-
Renoprotective effects of oleanolic acid and its possible mechanisms in rats with diabetic kidney disease(BMU101-EN-3.322)
Author:Liu Y, Hu Z, Xing H, et al. Publication name:Biochemical and Biophysical Research Communications IF:3.322
-
MicroRNA-29a-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting Roundabout homolog 1 in hepatic stellate cells(BMU101-EN-3.2)
Author:Kong, Hongyan, et al. Publication name:Parasites & Vectors IF:3.2
-
Hydrogen inhalation therapy regulates lactic acid metabolism following subarachnoid hemorrhage through the HIF-1α pathway(BMU101-EN-3.1)
Author:Peng, Zheng, et al. Publication name:Biochemical and Biophysical Research Communications IF:3.1
-
Intrathecal administration of botulinum toxin type a antagonizes neuropathic pain by countering increased vesicular nucleotide transporter expression in the spinal …(BMU101-EN-2.9)
Author:Shi, Yongqiang, et al. Publication name:Neuropeptides IF:2.9
-
Icariin promotes osteogenic differentiation by upregulating alpha-enolase expression(BMU101-EN-2.7)
Author:Xie, Dingbang, et al. Publication name:Biochemistry and Biophysics Reports IF:2.7
-
LncRNA LINC01871 sponging miR-142-3p to modulate ZYG11B promotes the chemoresistance of colorectal cancer cells by inducing autophagy(BMU101-EN-2.3)
Author:Duan, Bensong, et al. Publication name:Anti-Cancer Drugs IF:2.3
-
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells(BMU101-EN-2.1)
Author:Wang, Jiahui, Mengqing Li, and Meng Li. Publication name:Veterinary and Comparative Oncology IF:2.1
-
Aloin Induces Gastric Cancer Cell Apoptosis via the miR-5683/HMGB1 Signal Axis(BMU101-EN-1.8)
Author:Chen, Xuelei, et al. Publication name:Natural Product Communications IF:1.8
-
PRMT5 methylating Smad4 activates TGF-β signaling and promotes colorectal cancer metastasis(BMU101-EN-/)
Author:Wang G, Liu A, Yu C, et al. Publication name:Research Square IF:/
-
NADPH-oxidase 4 promotes autophagy in spinal neurons through activating ER stress during the development of morphine tolerance(BMU101-EN-)
Author:Xiao, Xuyang, et al. Publication name: IF:
Reviews
There are no reviews yet.